What is the treatment for decompensated cirrhosis of the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Decompensated Cirrhosis of the Liver

The treatment of decompensated cirrhosis requires a comprehensive approach targeting specific complications including ascites, variceal bleeding, hepatic encephalopathy, and spontaneous bacterial peritonitis, with the ultimate consideration of liver transplantation for eligible patients. 1, 2

Management of Ascites

First-line Treatment:

  • Sodium restriction (80-120 mmol/day or 4.6-6.9 g salt/day) 1
  • Diuretic therapy:
    • Start with spironolactone 50-100 mg/day (can increase up to 400 mg/day) 1, 3
    • Add furosemide 20-40 mg/day (up to 160 mg/day) if response to spironolactone is insufficient 1
    • Maintain spironolactone:furosemide ratio of 2.5:1 to 5:1 1

For Tense Ascites (Grade 3):

  • Large volume paracentesis (LVP) with albumin replacement (8g per liter of ascites removed if >5L is removed) 1
  • Continue diuretics after paracentesis to prevent reaccumulation 4

For Refractory Ascites:

  • Consider transjugular intrahepatic portosystemic shunt (TIPS) evaluation or scheduled LVP with albumin replacement 1
  • TIPS contraindications: age >70 years, serum bilirubin >50 μmol/L, platelet count <75×10^9/L, MELD score ≥18, or current hepatic encephalopathy 1

Management of Variceal Bleeding

Acute Variceal Bleeding:

  • Initiate vasoactive drugs (terlipressin, somatostatin, or octreotide) as soon as bleeding is suspected and continue for 3-5 days 5
  • Perform endoscopic variceal ligation within 12 hours after admission once hemodynamically stable 5
  • Administer prophylactic antibiotics: Ceftriaxone (1 g/24 h) for up to 7 days in patients with advanced cirrhosis or oral quinolones (norfloxacin 400 mg twice daily) in other patients 5
  • Volume replacement with colloids and/or crystalloids (avoid starch) to maintain hemodynamic stability 5
  • Restrictive transfusion strategy with hemoglobin threshold of 7 g/dl and target range of 7-9 g/dl 5
  • Consider early pre-emptive covered TIPS (within 24-72 hours) in high-risk patients 5

Primary Prophylaxis:

  • Propranolol starting with 40 mg twice daily, increasing to 80 mg twice daily if necessary 1
  • Goal: reduce portal pressure to less than 12 mm Hg 1
  • Alternative: endoscopic variceal ligation or isosorbide mononitrate (20 mg twice daily) 1

Management of Hepatic Encephalopathy

  • Lactulose or lactitol when encephalopathy develops 5, 2
  • Rifaximin may be added for recurrent episodes 2
  • Avoid nephrotoxic drugs, large volume paracentesis, beta-blockers, vasodilators, and other hypotensive drugs during acute variceal hemorrhage 5
  • Discontinue medications that may worsen ascites (NSAIDs, ACE inhibitors, Angiotensin receptor blockers) 1

Management of Infections

Spontaneous Bacterial Peritonitis (SBP):

  • Diagnostic paracentesis for new-onset ascites to rule out infection 1
  • If SBP diagnosed, initiate antibiotics and albumin infusion (1.5 g/kg on day 1, followed by 1 g/kg on day 3) 1
  • Third-generation cephalosporins are the antibiotics of choice 6

Monitoring and Screening

  • Regular weight measurements and periodic ultrasound examinations to track fluid status 1
  • Screen for hepatocellular carcinoma at diagnosis and then every 6 months 1, 7
  • Endoscopic monitoring: every 3 years if no varices are present, annually if small varices are present 1
  • Calculate Child-Pugh and MELD scores every 6 months 7

Liver Transplantation

  • Consider evaluation for liver transplantation in patients with MELD score ≥15, complications of cirrhosis, or hepatocellular carcinoma 7
  • Patients with ascites have a poor prognosis (40-50% mortality at 1-2 years) and should be considered for transplant evaluation 1

Cautions and Pitfalls

  • Initiate diuretic therapy cautiously in patients with cirrhosis, preferably in a hospital setting 3, 8
  • Monitor for electrolyte imbalances, particularly hypokalemia and hyponatremia 8
  • Avoid overdiuresis as it can precipitate hepatic encephalopathy (occurs in ~26% of cases) 1
  • Avoid nephrotoxic drugs such as aminoglycosides and NSAIDs 5, 1
  • Monitor weight loss: should not exceed 0.5 kg/day in patients without peripheral edema and 1 kg/day in patients with peripheral edema 1

References

Guideline

Management of Liver Cirrhosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liver Disease: Cirrhosis.

FP essentials, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.